MAPT and Alzheimer disease: It is worth stressing that specific tau-reactive antibodies may be also generated in response to the presentation of tau as new self-antigen, which might contribute to the immune imbalance in AD, and potentially lead to neuroinflammatory response, aggravating the progression of the disease.